Brighton Jones’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34.6K Sell
10,822
-7,654
-41% -$29.6K ﹤0.01% 1366
2026
Q2
$56.4K Buy
+18,476
New +$73.4K ﹤0.01% 1361

Other funds holding LRMR

Brighton Jones's LRMR Position: Q3 2026 in Review

Brighton Jones reduced its Larimar Therapeutics (LRMR) stake by 41% in Q3 2026, selling an estimated $29.6K and leaving 10,822 shares worth $34.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1366.

Brighton Jones first reported a position in LRMR in Q2 2026 and has held it in 2 quarters since. The position peaked at $56.4K in Q2 2026. 113 funds tracked by Wall St. Rank hold LRMR as of Q3 2026.

  • Brighton Jones held 10,822 shares of Larimar Therapeutics worth $34.6K as of Q3 2026.
  • Brighton Jones sold 7,654 Larimar Therapeutics shares in Q3 2026, an estimated $29.6K.
  • Larimar Therapeutics made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1366 holding.
  • Brighton Jones first reported a position in Larimar Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Brighton Jones's Larimar Therapeutics position peaked at $56.4K in Q2 2026.
  • 113 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.